Smartleaf Asset Management »

Century Therapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.6k 1.6k 1.61

More positions owned by Smartleaf Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Us Quality Grow (QGRW)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Smartleaf Asset Management

Top funds holding Century Therapeutics

VR Adviser
Boxer Capital
Casdin Capital
BlackRock
DAFNA Capital Management
Geode Capital Management
Tang Capital Management
Baker Bros. Advisors
Octagon Capital Advisors
Renaissance Technologies
Charles Schwab Investment Management
Northern Trust
Acadian Asset Management
Bank of New York Mellon
Jpmorgan Chase & Co

View all funds holding Century Therapeutics